ResearchAarkstoreEnterprise Disease and Therapy Review: Diabetes http://www.aarkstore.com/publishers/pubreports.asp? PubId=38&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Disease&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Therapy%20&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Review&PubId=&pagenum=1 Summary Datamonitor's Teradata Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. Teradata Corporation - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Teradata Corporation (Teradata or the company) is a provider of enterprise data warehousing, including enterprise analytic technologies and services. Its data warehousing solutions include the database and application software, hardware platform, and related consulting and support services. The company primarily operates in the US. It is headquartered in Dayton, Ohio, and employs about 7,400 people. The company recorded revenues of $1,936 million during the financial year ended December 2010 (FY2010), an increase of 13.3% over 2009. The increase was primarily driven by higher product revenue, particularly in the Americas region. The operating profit of the company was $415 million in FY2010, an increase of 22.8% over 2009. Its net profit was $301 million in FY2010, an increase of 18.5% over 2009.
Scope of the Report
- Provides all the crucial information on Teradata Corporation required for business and competitor intelligence needs - Contains a study of the major internal and external factors affecting Teradata Corporation in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Teradata Corporation -Data is supplemented with details on Teradata Corporation history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Teradata Corporation Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Qualify prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available
Table of Contents :
SWOT COMPANY PROFILE: Teradata Corporation Key Facts: Teradata Corporation Company Overview: Teradata Corporation Business Description: Teradata Corporation Company History: Teradata Corporation Key Employees: Teradata Corporation Key Employee Biographies: Teradata Corporation Products & Services Listing: Teradata Corporation Products & Services Analysis: Teradata Corporation SWOT analysis: Teradata Corporation *Strengths: Teradata Corporation
*Weaknesses: Teradata Corporation *Opportunities: Teradata Corporation *Threats: Teradata Corporation Company View: Teradata Corporation Top Competitors: Teradata Corporation Location and Subsidiary: Teradata Corporation *Head Office: Teradata Corporation *Other Locations and Subsidiaries: Teradata Corporation For more information please visit link: http://www.aarkstore.com/reports/Disease-and-Therapy-Review-Diabetes-6606.html Neel Aarkstore Enterprise Phone:08149852585 Email:enquiry@aarkstore.com URL:www.aarkstore.com http://www.facebook.com/aarkstoreenterprise
Disease and Therapy Review: ESRD Disease and Therapy Review: Alzheimer Disease Disease and Therapy Review: Migraine Disease and Therapy Review: Stroke Disease and Therapy Review: Rheumatoid Arthritis Disease and Therapy Review: Obesity Disease and Therapy Review:Major Depressive Disorder Disease and Therapy Review: HIV/AIDS Disease and Therapy Review: Epilepsy Disease and Therapy Review: Parkinson's Disease
Disease and Therapy Review: Heart Failure Disease and Therapy Review: Hepatitis C Disease and Therapy Review: Bipolar Disorder Disease and Therapy Review: Breast Cancer Asthma – Executive Market Summary 2011 Bladder Cancer – Executive Market Summary 2011 Colorectal Cancer – Executive Market Summary 2011 Chronic Obstructive Pulmonary Disease (COPD) – Executive Market Summary 2011 Onychomycosis – Executive Market Summary 2011 Ulcerative Colitis – Executive Market Summary 2011 Impetigo – Executive Market Summary 2011